Spherical mesoporous nanoparticles (MNPs) with a diameter of ~100 nm were synthesised via a sol-gel method in the presences of organic template (with and without fluorescein dye encapsulation). The template molecules were removed by acidic extraction to form a regular pore lattice structure. The nanoparticle size and morphology were analysed using transmission electron microscopy and dynamic light scattering analysis. The MNPs were further characterised by zeta potential, nitrogen adsorption measurements and infra-red spectroscopy. The interior pores had an average diameter of ~3 nm and were loaded with an endothelial-independent vasodilator, sodium nitroprusside (SNP). The optimal drug loading and drug release was determined in high potassium physiological salt solution using dialysis and atomic absorption spectroscopy.
Introduction
Progress in nanoparticle fabrication techniques has enabled the tailoring of nanoparticle properties for the development of innovatively designed biological drug delivery vehicles [1] [2] [3] . Orally and intravenously administered drugs circulate throughout the body and may have a number of systemic side effects, often leading to poor efficiency of the drug [4] . Consequently, there is a drive for the development of new drug delivery systems. In particular, mesoporous nanoparticles (MNPs) can be fabricated using colloidal methods with small diameters that are able to enter cells. Regular pore structure is produced during the surfactant template synthesis method [5] . The resulting MNPs have high surface to volume ratio's with pore channels that can be loaded with guest molecules. The exterior surface is available for functionalisation to enable targeted therapy of intracellular structures [6] . Furthermore, these particles have been used for diagnostic imaging and cellular localisation by confocal microscopy and flow cytometry by incorporation of fluorescent dye molecules within the MNPs silica framework [7] . Once the nanoparticles have been drug loaded, the release is governed by constrained pore diffusion enabling these particles to be utilised for slow drug release applications [8, 9] . Previous studies have used MNPs as hosts (such as MCM-41and SBA-15) and loaded with guest molecules (such as drugs, enzymes, DNA and luminescent dyes) to produce effective systems in which the host-guest interaction plays a vital role in their application [10] .
The ordered pore network of MNPs allows fine control of the drug loading and release kinetics, while the large surface area allows adsorption of the required dosage of drug [5] . Release kinetics has been demonstrated from MNPs using luminescent molecules and ibuprofen [9, [11] [12] [13] [14] . One study showed that 80 % of ibuprofen was released after only 50 min from MNPs with pore size of 3.4 nm and particle diameter of 50 µm [15] . Another study demonstrated that it took 31 h for the release of 60 % of ibuprofen loaded into MNPs (diameter 950 nm and pore size of 2.5 nm). There has been an abundance of studies showing that MNPs are internalised into the cytoplasm of mammalian cells with low cytotoxicity (LD 50 values greater than 1mg mL -1 ) demonstrating their biocompatibility [16] .
The aortic vessel is the largest artery in vertebrates and plays an important role in the transport of blood and the maintenance of blood pressure (Fig. 1) . Arteries are comprised of three layers, an endothelial layer facing the lumen, a smooth muscle layer, and an outer adventitial layer [17] . Vessel viability and the integrity of the endothelial and smooth muscle cell layers can be verified by examining vascular responses to vasodilator and vasoconstrictor agonists [18] . A major vasodilator released naturally by endothelial cells is nitric oxide (NO) and is important in the maintenance of vessel diameter.
Reduced bioavailability of NO has been demonstrated in a number of vascular related conditions, including diabetes and hypertension [19] . The development of nanoparticles that can deliver sustained and controlled release of NO could have enormous impact on human health. One approach has been the development of silica hydrogel nanoparticle matrices, whereby the entrapped NO molecules are released when exposed to moisture [20] . Sodium nitroprusside (SNP) is an endothelial independent vasodilator that causes relaxation of the smooth muscle cells by delivery of NO, which is a labile ligand, contained within the SNP molecular complex [21] [22] [23] . In this study, we report for the first time the in vitro real-time vasodilator action of SNP on arterial vessels delivered via MNPs. Controlled release of SNP from MNPs is a promising avenue for the development of therapeutic intervention in cardiovascular disease.
Materials and methods

Materials
Fluorescein isothiocyanate (FITC), (3-aminopropyl)trimethoxysilane (APTMS), tetraethyl orthosilicate (TEOS), hydrochloric acid (HCl, 37 %) and sodium nitroprusside (SNP) were purchased from Sigma-Aldrich. Hexadecyltrimethyammonium bromide (CTAB), anhydrous dimethylformamide (DMF), sodium hydroxide (NaOH) and methanol (MeOH) were purchased from Fisher-Scientific. Salt solutions were prepared using sodium chloride (NaCl), potassium chloride (KCl), magnesium sulphate 
Synthesis of non-dye encapsulated mesoporous nanoparticles
Mesoporous silica nanoparticles (MNPs) were synthesised using a modified template directed self-assembly method published by Slowing et al without the incorporation of FITC dye molecules [25] . Briefly, anhydrous DMF (5 mL) was mixed with APTMS (50 µL). CTAB (1 g) was dissolved in H 2 O (480 mL) and 2 M NaOH solution (3.5 mL) was added and stirred at 80 °C. TEOS (4 mL) was added followed by the addition of the APTMS mixture (500 µL). The resulting mixture was stirred vigorously at 80 °C for 2 h producing an opaque white suspension. The MNPs were collected and washed with MeOH by centrifugation (14,000 rpm/ 15 min) several times.
The surfactant template (CTAB) was extracted from the as-synthesised product by refluxing the product in MeOH (200 mL) and concentrated HCl (2 mL) for 24 h. The MNPs were washed using the same procedure as before. The acid extraction step was repeated twice.
Synthesis of dye encapsulated mesoporous nanoparticles
Fluorescein isothiocyanate encapsulated mesoporous nanoparticles (FITC MNPs) were synthesised via the same method as the MNPs except that FITC (2.5 mg) was added to the mixture of anhydrous DMF and APTMS and then stirred for 3 h. [25] . The resulting product was a yellow suspension.
Characterisation of mesoporous nanoparticles
The MNPs hydrodynamic size and zeta potential were determined by dynamic light scattering (DLS) and laser Doppler velocimetry respectively (Malvern Zetasizer nano ZS instrument). The zeta potential was determined for MNPs in both distilled water and KPSS. The MNP sizes were further confirmed using scanning electron microscopy (SEM, JEOL 5600LV SEM) and transmission electron microscopy (TEM, Philips The infra-red analysis was used for confirmation of template removal (Nicolet Avatar 360 FT-IR). Fluorescence spectroscopy was used to determine the encapsulation of dye molecules within the MNPs by producing a calibration plot of know concentrations of FITC dye molecules (Hitachi fluorescence spectrophotometer F-2500).
Drug loading efficiency
Drug loading efficiency was calculated using equation 1 below [26] . 250 mg of MNPs with and without dye molecules were suspended into 25 mL of the SNP methanol solution (1×10 
Vascular functional studies
The thoracic aortic arteries of male Wistar rats were used for the in vitro studies were placed under a constant 2 g tension throughout the experimentation as preliminary results have determined this to be the optimal tension value. Vessels were equilibrated for approximately 1 hour, followed by pre-constriction with high K⁺ (60 mM, KCl) to test vessel viability and achieve stable contraction, as previously described by Farooq et al [24] . Responses to SNP were examined by adding cumulative doses of SNP (0. were incubated with constricted vessels over a 3 h period. The number of nanoparticles per mL was determined by calculating the volume and density of a sphere with a diameter of 100 nm and finally the mass of a mesoporous nanoparticle; the density of mesoporous silica was 0.814 g cm -3
[27].
Release of sodium nitroprusside from mesoporous nanoparticles in vitro
The effect of the SNP loaded MNPs and FITC MNPs was examine by addition of
to preconstricted vessels using the approach described above.
Transmission electron microscopy
Vessels tested in the release studies were fixed immediately after the functional studies, using 2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3) for 2 h at 22 ˚C. The samples were postfixed with reduced osmium (OsO 4 1 % + K 4 Fe(CN) 6 1.5 %) for 1 h, then dehydrated in a series of alcohols, infiltrated with TAAB LV resin and polymerized for 24 h at 60 ˚C, as previously described (Akbar et al. [28] ). Ultrathin 70 nm sections were cut with Leica 'Ultracut S' ultramicrotome and placed on formvar carbon coated TEM copper grids (Agar Scientific). The samples were observed using a Tecnai 12 Biotwin TEM at 80 kV as previously described by Farooq et al. [24] .
Statistical analysis
Data are expressed as mean ± standard error of mean (S.E.M.) with 'n'
representing the number of vessels. Dilator responses are expressed as percent relaxation.
Concentration response curves were assessed using statistical package for the social sciences (SPSS; version 19). The difference between groups at a given concentration was tested by one way analysis of variance (ANOVA) with Bonferroni corrections. Statistical significance is taken as P<0.05 as previously described by Farooq et al [24] .
Results and discussion
Mesoporous silica nanoparticles
The SEM images in Fig. 3 confirm that particles produced have a narrow size distribution with an average diameter of 95±13 nm for MNPs (Fig. 3A) and 109±18 nm for the FITC MNPs (Fig. 3B) . The TEM images showed that the MNPs (Fig. 4A ) and FITC MNPs (Fig. 4B) were mainly spherical in shape with some variation in the size distributions. The particles had regular, parallel-aligned pore channels confirming the successful removal of the template using the acid extraction method. DLS measurements showed that the average hydrodynamic diameter of the as-synthesised MNPs was 182.9
nm and the FITC MNPs was 183.9 nm with a polydispersion index of 0.49 and 0.4 respectively ( Fig. S1 ). were diminished.
The amount of dye molecules encapsulated within the silica framework of the MNPs was quantified with fluorescence spectroscopy. The fluorescence spectra of known concentrations of FITC were used to produce a calibration graph (Fig. S2) . The excitation wavelength of FITC is 490 nm with an emission at 520 nm. The dye molecules encapsulated within the MNP were quantified by analysing the amount of dye molecules within the supernatant after centrifugation from the reaction media. Thus, the dye concentration within the MNPs was calculated by subtracting the concentration within the supernatant from the actual concentration of dye used ( Table 2 ). The mass of FITC dye molecules within FITC MNPs was determined to be 2.48 mg. The FITC MNPs demonstrated a strong fluorescent signal (Fig. S3 ).
The nitrogen adsorption and desorption of the MNPs follows the general
Langmuir isotherm trend of mesoporous materials (Fig. 6 ) indicating monolayer adsorption of gas within the capillaries of the pores. From the gas adsorption analysis it was possible to determine that the silica MNPs have a pore diameter of 2.9 nm as shown in the pore size distribution graph (insert in Fig. 6A ). The overall surface area was determined as 853.3 ± 9.0 m²g , which is larger than the silica MNPs, while the insert confirm the pore size to be 2.8 nm, similar to the silica MNPs (Fig. 6B ). All the isotherms indicate that ordered mesopores are present in the samples (the step at ~0.4 p/ p o ).
Sodium nitroprusside release from mesoporous nanoparticles
The concentration of SNP was calculated from iron concentration which originated from the SNP drug and is shown in Table 3 . The drug loading efficiency of the MNPs was determined to be 86.30 % whilst for the FITC MNPs it was 96.46% for 250mg of the particles, indicating that nearly all the SNP drug was adsorbed when soaked in a concentration of 1×10 -5 mol dm -3 SNP. There was a higher amount of drug adsorption by the FITC MNPs as there may be residual amine functional groups from the dye coupling reaction causing electrostatic attraction of SNP on the pore surface.
The release rate of SNP from MNPs and FITC MNPs was investigated (Fig. 7) .
The time course of SNP release demonstrates that there is a rapid initial release for both types of MNPs over 10 min, this is expected due to the large concentration gradient but also due to some desorption on the particle exterior surface. From 10 min to 180 min there is a shallow gradient in the graph indicating slow release.
Detection of mesoporous nanoparticles within vascular tissue
In the present study, we demonstrate that the exposure of viable aortic vessels to (Fig. 10) . The FITC MNPs loaded with SNP leads to a rapid relaxation of aortic vessels however, the relaxation was sustained over 120 min, thereafter followed by re-constriction. The statistical analysis confirms that the relaxation is significant for the SNP loaded FITC MNPs ( Table 4 ).
The dosage of MNPs added to the aortic vessels was 1.96×10 12 NP mL -1 was the same concentration used in our previous study in which we tested non-porous silica nanoparticles (71±6 nm) [24] . In line with our previous observations with non-porous silica nanoparticles, the MNPs and FITC MNPs had no detriment to the endothelialindependent vasodilation indicating good biocompatibility. This is in good agreement with the literature where human cervical cancer cells (HeLa) were exposed to 100 µg mL -1 of FITC MNPs and no difference between the control and the FITC MNPs cell growth profile were shown thus confirming they are not cytotoxic [25] .
Data from the in vitro real-time release studies were used to construct percentage relaxation graphs to SNP from MNPs (shown in Fig. 9B ). There was no statistically significant difference over the 3 h exposure time period between the KPSS control and high concentration of MNPs (Table 4) . Furthermore, the exposure of viable aortic vessels to MNPs loaded with SNP led to a rapid relaxation of the vessels. The MNPs loaded with SNP led to an initial sharp release of SNP within the first 20 min leading to 57.74 % relaxation. The maximum relaxation was 77.08 % and was reached at 125 min.
Similarly, for the percentage relaxation graphs of MNPs, there was no statistically significant affect over the 3 h exposure time period between the KPSS control and FITC MNPs (Fig. 11B) . Also, the MNPs loaded with SNP, led to a rapid relaxation of the vessels. The FITC MNPs loaded with SNP led to an initial sharp release of SNP within the first 20 min leading to 61.93 % relaxation. The maximum relaxation was 64.16 % and was reached at 35 min.
In order to calculate the SNP release in real-time under physiological conditions, a calibration plot of known concentrations of SNP against relaxation was constructed (Fig.   11 ). The logarithm equation, determined from the calibration plot, allowed for the calculation of SNP concentration released at a given time ( Table 5 ). The calculated SNP release from the MNP with and without dye estimated from the calibration plot using the in vitro studies showed that the concentration of SNP after 180 minutes was similar to the release study in the dialysis tubing supernatant determined with atomic absorption spectroscopy ( Table 6 ). There was a lower concentration in vitro which is expected as the relaxation occurs from the dissociation of the NO ligand from the SNP, which diffuses through to the smooth muscle cells of the vessel.
Conclusions
In conclusion, we have designed a drug delivery system allowing the release of a model drug -sodium nitroprusside (SNP agonist) from the mesoporous matrix. MNPs with an average size of 100 nm were used in the experiments in pure form or after encapsulation of a fluorescein isothiocyanate dye (FITC MNPs). The drug-loaded particles were added to isolated aortic vessels to record the real-time release profile, ex vivo. Vessel relaxation was evident over a 3 h duration of the incubation period for both MNPs and FITC MNPs.
We have created a biocompatible slow release drug delivery vehicle that can deliver 
